Literature DB >> 16464987

Definition of disease duration in ankylosing spondylitis: reassessing the concept.

J C Davis1, M Dougados, J Braun, J Sieper, D van der Heijde, S van der Linden.   

Abstract

The concept and definition of disease duration in patients with ankylosing spondylitis is ambiguous, and often many years pass between the onset of symptoms and diagnosis. Members of the Assessment in Ankylosing Spondylitis (ASAS) International Working Group by consensus recently recommended identifying specific components of the medical history to better define and document the concept of disease duration. These include (1) the time of onset of the first symptoms of axial manifestations (including inflammatory back pain); (2) the time of onset of the first symptoms of each individual manifestation, which may be an extra-axial sign or symptom of ankylosing spondylitis, such as peripheral arthritis and enthesitis; (3) the time of onset of associated diseases belonging to the spondyloarthritides, in particular acute anterior uveitis, inflammatory bowel disease and psoriasis; and (4) the time since actual diagnosis by a healthcare provider. Such uniformity in data collection will ensure comparability across studies and facilitate future research.

Entities:  

Mesh:

Year:  2006        PMID: 16464987      PMCID: PMC1798344          DOI: 10.1136/ard.2005.044834

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  7 in total

1.  A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis.

Authors:  A Spoorenberg; D van der Heijde; E de Klerk; M Dougados; K de Vlam; H Mielants; H van der Tempel; S van der Linden
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

2.  Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression.

Authors:  S Brophy; A Calin
Journal:  J Rheumatol       Date:  2001-10       Impact factor: 4.666

3.  The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population.

Authors:  S M van der Linden; H A Valkenburg; B M de Jongh; A Cats
Journal:  Arthritis Rheum       Date:  1984-03

4.  The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients.

Authors:  A Zink; J Listing; C Klindworth; H Zeidler
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

5.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Authors:  M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero
Journal:  Arthritis Rheum       Date:  1991-10

6.  Disability motivates patients with ankylosing spondylitis for more frequent physical exercise.

Authors:  Albrecht Falkenbach
Journal:  Arch Phys Med Rehabil       Date:  2003-03       Impact factor: 3.966

7.  The natural history of ankylosing spondylitis as defined by radiological progression.

Authors:  Sinead Brophy; Kirsten Mackay; Ahmed Al-Saidi; Gordon Taylor; Andrei Calin
Journal:  J Rheumatol       Date:  2002-06       Impact factor: 4.666

  7 in total
  6 in total

1.  Definition of disease duration in ankylosing spondylitis.

Authors:  Ernst Feldtkeller; Jon Erlendsson
Journal:  Rheumatol Int       Date:  2007-12-12       Impact factor: 2.631

2.  Demographic, clinical, and laboratory features of Turkish patients with late onset ankylosing spondylitis.

Authors:  Ahmet Karaarslan; Hatice Yilmaz; Hakan Aycan; Mehmet Orman; Senol Kobak
Journal:  Bosn J Basic Med Sci       Date:  2015-07-22       Impact factor: 3.363

3.  Relationship between diagnosis delay and disease features in Moroccan patients with ankylosing spondylitis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Rachida Bensabbah; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2010-11-26       Impact factor: 2.631

4.  Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies.

Authors:  M A C van der Weijden; J C van Denderen; W F Lems; M W Heymans; B A C Dijkmans; I E van der Horst-Bruinsma
Journal:  Clin Rheumatol       Date:  2010-08-10       Impact factor: 2.980

5.  First signs and symptoms of spondyloarthritis--data from an inception cohort with a disease course of two years or less (REGISPONSER-Early).

Authors:  Marena Rojas-Vargas; Elisa Muñoz-Gomariz; Alejandro Escudero; Pilar Font; Pedro Zarco; Raquel Almodovar; Jordi Gratacós; Juan Mulero; Xavier Juanola; Carlos Montilla; Estefanía Moreno; Eduardo Collantes-Estevez
Journal:  Rheumatology (Oxford)       Date:  2009-02-10       Impact factor: 7.580

6.  Delayed treatment with a tumor necrosis factor alpha blocker associated with worse outcomes in patients with spondyloarthritis: data from the Czech National Registry ATTRA.

Authors:  Tomas Milota; Jana Hurnakova; Karel Pavelka; Zlatuse Kristkova; Lucie Nekvindova; Rudolf Horvath
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-03-17       Impact factor: 5.346

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.